Detalhe da pesquisa
1.
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial.
JAMA
; 328(4): 348-359, 2022 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35881122
2.
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next.
JAMA Netw Open
; 7(4): e248383, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687481
3.
Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.
Eye (Lond)
; 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38200320
4.
Correction: Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.
Eye (Lond)
; 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38332376
5.
Leydig cells of the human testis possess astrocyte and oligodendrocyte marker molecules.
Acta Histochem
; 104(1): 39-49, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-11993850